IL108623A0 - Silylated acetylcholinesterase inhibitors - Google Patents

Silylated acetylcholinesterase inhibitors

Info

Publication number
IL108623A0
IL108623A0 IL10862394A IL10862394A IL108623A0 IL 108623 A0 IL108623 A0 IL 108623A0 IL 10862394 A IL10862394 A IL 10862394A IL 10862394 A IL10862394 A IL 10862394A IL 108623 A0 IL108623 A0 IL 108623A0
Authority
IL
Israel
Prior art keywords
silylated
acetylcholinesterase inhibitors
compounds
methods
acetylcholinesterase
Prior art date
Application number
IL10862394A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL108623A0 publication Critical patent/IL108623A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
IL10862394A 1993-02-16 1994-02-11 Silylated acetylcholinesterase inhibitors IL108623A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93400385A EP0611769A1 (en) 1993-02-16 1993-02-16 Silylated acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
IL108623A0 true IL108623A0 (en) 1994-05-30

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10862394A IL108623A0 (en) 1993-02-16 1994-02-11 Silylated acetylcholinesterase inhibitors

Country Status (19)

Country Link
EP (2) EP0611769A1 (hu)
JP (1) JP3516955B2 (hu)
KR (1) KR100336547B1 (hu)
CN (1) CN1043575C (hu)
AT (1) ATE152725T1 (hu)
AU (1) AU672885B2 (hu)
CA (1) CA2154870C (hu)
DE (1) DE69403068T2 (hu)
DK (1) DK0684951T3 (hu)
ES (1) ES2104358T3 (hu)
FI (1) FI111461B (hu)
GR (1) GR3024151T3 (hu)
HU (1) HUT72736A (hu)
IL (1) IL108623A0 (hu)
MX (1) MX9401175A (hu)
NO (1) NO305517B1 (hu)
NZ (1) NZ262247A (hu)
WO (1) WO1994019356A1 (hu)
ZA (1) ZA94925B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术(上海)有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
DK2091948T3 (da) 2006-11-30 2012-07-23 Probiodrug Ag Nye inhibitorer af glutaminylcyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物,其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
HUT72736A (en) 1996-05-28
EP0611769A1 (en) 1994-08-24
CA2154870C (en) 1998-10-27
EP0684951B1 (en) 1997-05-07
NO305517B1 (no) 1999-06-14
NO953201D0 (no) 1995-08-15
KR100336547B1 (ko) 2002-11-02
MX9401175A (es) 1994-08-31
WO1994019356A1 (en) 1994-09-01
JP3516955B2 (ja) 2004-04-05
CA2154870A1 (en) 1994-09-01
NO953201L (no) 1995-08-15
FI111461B (fi) 2003-07-31
AU672885B2 (en) 1996-10-17
DE69403068D1 (en) 1997-06-12
KR960701068A (ko) 1996-02-24
GR3024151T3 (en) 1997-10-31
NZ262247A (en) 1996-01-26
FI953851A0 (fi) 1995-08-15
CN1043575C (zh) 1999-06-09
ATE152725T1 (de) 1997-05-15
JPH08507059A (ja) 1996-07-30
DK0684951T3 (da) 1997-05-26
AU6164194A (en) 1994-09-14
DE69403068T2 (de) 1997-12-11
ES2104358T3 (es) 1997-10-01
ZA94925B (en) 1994-08-25
FI953851A (fi) 1995-08-15
CN1117733A (zh) 1996-02-28
EP0684951A1 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
HU9503452D0 (en) Aromatic acetylcholinesterase inhibitors
GR3024151T3 (en) Silylated acetylcholinesterase inhibitors.
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
GR3030269T3 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus.
EP0630383A4 (en) METHODS OF TREATING DIABETES.
EP0710106A4 (en) METHOD FOR TREATING ADDICTIVE BEHAVIOR
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines
GB9317943D0 (en) Treatment of laminitis
EP0654996A4 (en) METHOD FOR TREATING PSORIASIS USING SUBSTITUTED AZASPIRANS.
GB9317989D0 (en) Treatment of laminitis
GB2269523B (en) Treating hides
HU9301187D0 (en) Method for treating tumours being dependent of gar-transformylase
EP0608702A3 (de) Verfahren zum Behandeln von Haselnüssen.
EP0932406A4 (en) METHODS OF TREATING OR PREVENTING INTERSTITIAL CYSTITIS
EP0654997A4 (en) COMPOSITIONS OF SUBSTITUTED AZASPIRANS AND METHOD FOR TREATING PSORIASIS THEREFOR.
GB9314466D0 (en) Methods of treating diamonds